Targeting CD39 boosts PD-1 blockade antitumor therapeutic efficacy via strengthening CD8â+âTILs function and recruiting B cells in cervical cancer.
靶向 CD39 可增强 PD-1 阻断抗肿瘤治疗效果,其机制是通过增强 CD8+TILs 功能和募集 B 细胞来治疗宫颈癌
期刊:Journal of Nanobiotechnology
影响因子:12.6
doi:10.1186/s12951-025-03500-0
Jiang Lili, Wu Tong, Qu Xinyu, Li Shuqi, Jiang Qi'an, Ren Tingting, Liang Jiali, Ding Yan, Hua Keqin, Tang Zhongmin, Qiu Junjun